Copyright
©The Author(s) 2022.
World J Clin Oncol. Jul 24, 2022; 13(7): 652-662
Published online Jul 24, 2022. doi: 10.5306/wjco.v13.i7.652
Published online Jul 24, 2022. doi: 10.5306/wjco.v13.i7.652
Figure 1 Biochemical relapse free survival according to radiotherapy indication (adjuvant versus salvage radiotherapy).
RT: Radiotherapy.
Figure 2
Biochemical failure-free survival according to radiotherapy dose to the surgical bed.
Figure 3
Overall survival according to total radiotherapy dose to the surgical bed.
Figure 4
Metastasis-free survival according to the total radiotherapy dose to surgical bed.
- Citation: Hervás-Morón A, Domínguez-Rullán J, Santana VD, Valero M, Vallejo C, Sancho S, Fuentes JDG, Cámara Gallego M, López-Campos F. Assessing radiation dose for postoperative radiotherapy in prostate cancer: Real world data. World J Clin Oncol 2022; 13(7): 652-662
- URL: https://www.wjgnet.com/2218-4333/full/v13/i7/652.htm
- DOI: https://dx.doi.org/10.5306/wjco.v13.i7.652